Recruiting

Observational Study

Sponsor:

McGill University Health Centre/Research Institute of the McGill University Health Centre

Code:

NCT01668186

Conditions

Peroxisome Biogenesis Disorder

Zellweger Spectrum Disorder

RCDP - Rhizomelic Chondrodysplasia Punctata

D-Bifunctional Protein Deficiency

Alpha-Methylacyl-CoA Racemase Deficiency

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Study Details

Brief summary:

The Peroxisome Biogenesis Disorders (PBD) are a group of inherited disorders due to defects in peroxisome assembly causing complex developmental and metabolic sequelae. In spite of advancements in peroxisome biology, the pathophysiology remains unknown, the spectrum of phenotypes poorly characterized and the natural history not yet systematically reported. Our aims are to further define this population clinically, biochemically and genetically. The investigators will prospectively follow patients from Canada, the US and internationally, and collect data from medical evaluations, blood, urine and imaging studies that would be performed on a clinical care basis. For patients who are unable to attend our clinic, we will collect all medical records and images since birth as well as subsequent records/images for the next 5 years or until the end of the study. Clinical data from medical records will be banked in our Peroxisomal Disorder Research Databank and Biobank. The investigators will use this information to identify standards of care and improve management.

Conditions

Peroxisome Biogenesis Disorder

Zellweger Spectrum Disorder

RCDP - Rhizomelic Chondrodysplasia Punctata

D-Bifunctional Protein Deficiency

Alpha-Methylacyl-CoA Racemase Deficiency

Study ID

NCT01668186

Start date

Jan, 2012

Status verified date

Dec, 2025

Completion date

Jan, 2031

Anticipated

Primary completion date

Jan, 2030

Anticipated

Eligibility Criteria

Eligibility Criteria

Sex: All

Age: 0+

Healthy Volunteers: Not accepted

Inclusion Criteria:

  • Diagnosis of PBD or
  • Single peroxisome enzyme/protein defect with phenotype similar to PBD

Exclusion Criteria:

  • Not a PBD
  • Not a single peroxisome enzyme/protein defect with phenotype similar to PBD

Study Design

Enrollment

244 participants

Anticipated

Interventions and Outcome Measures

Arms

Patients diagnosed with a peroxisomal disorder

Collection of medical records and images (ultrasounds, X-rays, MRIs, CT scans, ophthalmic images), Next-generation panel, Drug screening, and Consultation

Primary outcome measure

  • Documentation of the clinical findings [ Time Frame: Yearly up to 10 years ]

Central Contacts and Locations

Central contacts

Locations

Research Institute of the McGill University Health Center

Recruiting

Montreal, Quebec, Canada, H4A 3J1

Principal Investigator:

Nancy E Braverman, MD, MS

More Information

Sponsor

McGill University Health Centre/Research Institute of the McGill University Health Centre

Last update posted

Dec 10, 2025

Last verified

Dec, 2025

Keywords

  • Peroxisome biogenesis disorders
  • PBD
  • Zellweger spectrum disorder
  • Rhizomelic chondrodysplasia punctata
  • DBP
  • ACOX1
  • AMACR
  • ARD
  • ACBD5
  • ZSD
  • RCDP
  • ACOX2
  • ABCD3
  • Adult Refsum
  • PHYH
  • SCPx
  • RCDP1
  • RCDP2
  • RCDP3

Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by McGill University Health Centre/Research Institute of the McGill University Health Centre on 2025-12-10.